This is the authors' abstract. We don't add key points for this paper.
The global problem of multidrug-resistant bacterial pathogens requires urgent actions, including the development of therapies supplementary or alternative to antibiotics. One of the infection control options could be phage therapy. This article gives a brief overview of phage therapy potentials as well as the challenges it faces in order to become a widely accepted form of infection treatment.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Чанішвілі et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: